ProKidney Corp. (PROK)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $417.20M
Last updated: Nov 17, 2026 at 11:04 AM ET
ProKidney Corp. (PROK) Earnings: Report Dates and Results
ProKidney (PROK) is expected to report earnings on Mar 16, 2027. In the quarter ended Sep 30, 2026, ProKidney reported EPS of -$0.17, below the -$0.13 estimate. It beat the EPS estimate in 4 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
PROK has an expected report date of Mar 16, 2027.
Earnings History
Of the 18 quarters below that had an estimate, PROK beat 12 and missed 6. Revenue for the quarter ended Sep 30, 2026 was $174000, down 19.8% from $217000 a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.17 | -$0.13 | -$0.17 - -$0.12 | -30.77% | Miss | N/A | 4 | 1 up, 2 down | Nov 12, 2026 | $174000 |
| Jun 30, 2026 | -$0.15 | -$0.13 | -$0.16 - -$0.11 | -15.38% | Miss | N/A | 5 | 3 up, 1 down | Aug 10, 2026 | $150000 |
| Mar 31, 2026 | -$0.14 | -$0.14 | -$0.16 - -$0.12 | -1.82% | Miss | N/A | 4 | 0 up, 0 down | May 15, 2026 | $226000 |
| Dec 31, 2025 | -$0.14 | -$0.15 | -$0.27 - -$0.10 | +6.67% | Beat | N/A | 6 | 2 up, 2 down | Mar 18, 2026 | $225000 |
| Sep 30, 2025 | -$0.12 | -$0.14 | -$0.16 - -$0.11 | +14.29% | Beat | N/A | 4 | 2 up, 1 down | Nov 10, 2025 | $217000 |
| Jun 30, 2025 | -$0.13 | -$0.14 | -$0.17 - -$0.13 | +7.14% | Beat | N/A | 5 | 2 up, 0 down | Aug 12, 2025 | $221000 |
| Mar 31, 2025 | -$0.13 | -$0.16 | -$0.16 - -$0.14 | +18.75% | Beat | N/A | 3 | 0 up, 0 down | May 12, 2025 | $230000 |
| Dec 31, 2024 | -$0.17 | -$0.15 | -$0.17 - -$0.13 | -13.33% | Miss | N/A | 5 | 2 up, 2 down | Mar 17, 2025 | $76000 |
| Sep 30, 2024 | -$0.14 | -$0.22 | N/A | +36.36% | Beat | N/A | 5 | 0 up, 0 down | Nov 12, 2024 | N/A |
| Jun 30, 2024 | -$0.16 | -$0.18 | -$0.19 - -$0.15 | +11.11% | Beat | N/A | 4 | 0 up, 0 down | Aug 9, 2024 | N/A |
| Mar 31, 2024 | -$0.16 | -$0.18 | -$0.18 - -$0.18 | +11.11% | Beat | N/A | 1 | 0 up, 0 down | May 10, 2024 | N/A |
| Dec 31, 2023 | -$0.09 | -$0.17 | -$0.18 - -$0.10 | +47.06% | Beat | N/A | 4 | 3 up, 0 down | Mar 21, 2024 | $4.49M |
| Sep 30, 2023 | -$0.18 | -$0.14 | -$0.22 - -$0.12 | -28.57% | Miss | N/A | 5 | 0 up, 0 down | Nov 14, 2023 | N/A |
| Jun 30, 2023 | -$0.14 | -$0.41 | -$0.66 - -$0.15 | +65.85% | Beat | N/A | 4 | 0 up, 0 down | Aug 10, 2023 | N/A |
| Mar 31, 2023 | -$0.16 | -$0.12 | -$0.66 - -$0.12 | -33.33% | Miss | N/A | 2 | 0 up, 0 down | May 11, 2023 | N/A |
| Dec 31, 2022 | -$0.11 | -$0.24 | -$0.65 - -$0.02 | +54.17% | Beat | N/A | 5 | 0 up, 0 down | Mar 28, 2023 | N/A |
| Sep 30, 2022 | -$0.13 | -$0.31 | -$0.76 - -$0.02 | +58.06% | Beat | N/A | 4 | 0 up, 0 down | Nov 14, 2022 | N/A |
| Jun 30, 2022 | -$0.06 | -$0.06 | N/A | +7.00% | Beat | N/A | N/A | N/A | Aug 12, 2022 | N/A |
| Mar 31, 2022 | -$0.12 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 16, 2022 | N/A |
| Dec 31, 2021 | -$0.06 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 24, 2022 | N/A |
| Sep 30, 2021 | -$0.01 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 15, 2021 | N/A |
| Jun 30, 2021 | -$0.01 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 16, 2021 | N/A |
| Mar 31, 2021 | Not reported | N/A | N/A | N/A | Not reported | N/A | N/A | N/A | Jun 9, 2021 | N/A |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$0.52, after -$0.63 the year before. It was -$0.08 for the year ended Dec 31, 2021, the oldest of the 5 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$0.52 | N/A |
| Dec 31, 2024 | -$0.63 | N/A |
| Dec 31, 2023 | -$0.57 | N/A |
| Dec 31, 2022 | -$0.42 | N/A |
| Dec 31, 2021 | -$0.08 | N/A |
Frequently Asked Questions About PROK
When is ProKidney's next earnings date?
ProKidney's next earnings report is expected for Mar 16, 2027.
Did PROK beat earnings estimates last quarter?
No. ProKidney reported EPS of -$0.17 for the quarter ended Sep 30, 2026, below the -$0.13 estimate by 30.77%.
What EPS do analysts expect from PROK next quarter?
The consensus EPS estimate for ProKidney for the quarter ending Dec 31, 2026 is -$0.14 from 8 analysts, with estimates from -$0.19 to -$0.12.
How often does PROK beat earnings estimates?
ProKidney beat the EPS estimate in 4 of the last 8 quarters, with an average surprise of -1.81%.
PROK pages: Overview, Earnings, Forecast, Financials, Competitors